ClinVar Miner

Submissions for variant NM_001277269.1(OTOG):c.(?_3914)-61_(6474_?)+67del

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000609156 SCV000712346 likely pathogenic Rare genetic deafness 2016-06-27 criteria provided, single submitter clinical testing The exon 32-37 deletion in OTOG has not been reported in individuals with hearin g loss, but several similarly sized deletions in OTOG have been reported in the Database of Genomic Variants (DGV, http://dgv.tcag.ca/dgv; variant accessions ID s: nsv469938, nsv553587, nsv467715, nsv951315, nsv520453). This variant results in the deletion of exons 32-37 of the OTOG gene, and is predicted to lead to a truncated or absent protein. Two loss of function variants in the OTOG gene have been reported to segregate with hearing loss in two families (Schraders 2012), and disruption of OTOG in mice resulted in deafness supporting a loss-of-functio n mechanism for the disease (Simmler 2000). In summary, although additional evid ence is required to strengthen the gene-disease association for OTOG and hearing loss, the current data support that the exon 32-37 deletion in OTOG is likely p athogenic for autosomal recessive hearing loss.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.